MCM
Matarin Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-28,453
| Closed | -$1.3M | – | 198 |
|
|
2020
Q3 | $1.3M | Buy |
28,453
+16,270
| +134% | +$745K | 0.27% | 135 |
|
|
2020
Q2 | $612K | Buy |
+12,183
| New | +$612K | 0.12% | 169 |
|
|
2020
Q1 | – | Sell |
-136,217
| Closed | -$8.42M | – | 217 |
|
|
2019
Q4 | $8.42M | Sell |
136,217
-64,554
| -32% | -$3.99M | 0.8% | 35 |
|
|
2019
Q3 | $12.1M | Sell |
200,771
-10,507
| -5% | -$631K | 0.91% | 30 |
|
|
2019
Q2 | $17.8M | Buy |
211,278
+1,875
| +0.9% | +$158K | 1.27% | 4 |
|
|
2019
Q1 | $20M | Sell |
209,403
-462
| -0.2% | -$44.1K | 1.46% | 1 |
|
|
2018
Q4 | $14.9M | Sell |
209,865
-343
| -0.2% | -$24.3K | 1.2% | 8 |
|
|
2018
Q3 | $18M | Buy |
210,208
+8,505
| +4% | +$727K | 1.16% | 12 |
|
|
2018
Q2 | $23.4M | Sell |
201,703
-21,804
| -10% | -$2.53M | 1.69% | 1 |
|
|
2018
Q1 | $18.1M | Sell |
223,507
-63,450
| -22% | -$5.13M | 1.36% | 5 |
|
|
2017
Q4 | $16.8M | Sell |
286,957
-3,664
| -1% | -$215K | 1.31% | 3 |
|
|
2017
Q3 | $13.6M | Buy |
290,621
+15,728
| +6% | +$736K | 1.16% | 6 |
|
|
2017
Q2 | $9.89M | Sell |
274,893
-71,083
| -21% | -$2.56M | 0.92% | 21 |
|
|
2017
Q1 | $10.7M | Buy |
345,976
+88,708
| +34% | +$2.73M | 1.05% | 14 |
|
|
2016
Q4 | $8.62M | Buy |
257,268
+10,420
| +4% | +$349K | 0.97% | 17 |
|
|
2016
Q3 | $6.57M | Buy |
246,848
+10,158
| +4% | +$270K | 0.72% | 44 |
|
|
2016
Q2 | $5.22M | Buy |
236,690
+17,654
| +8% | +$389K | 0.71% | 53 |
|
|
2016
Q1 | $6.43M | Buy |
219,036
+78,407
| +56% | +$2.3M | 0.9% | 24 |
|
|
2015
Q4 | $4.64M | Buy |
140,629
+93,274
| +197% | +$3.08M | 0.69% | 54 |
|
|
2015
Q3 | $1.71M | Buy |
+47,355
| New | +$1.71M | 0.35% | 97 |
|